The role of immune semaphorins in the pathogenesis of multiple sclerosis: Potential therapeutic targets
Article in International Immunopharmacology (March 2021)
The most recent citing publications are shown below. View all 27 publications that cite this research output on Dimensions.
Interferon-β Is Less Effective Than Other Drugs in Controlling the Rate of Retinal Ganglion Cell Loss in MS.
Article in Neurology Neuroimmunology & Neuroinflammation (February 2021)
Switching treatments in clinically stable relapsing remitting multiple sclerosis patients planning for pregnancy
Article in Multiple Sclerosis Journal - Experimental Translational and Clinical (January 2021)